The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials

被引:48
|
作者
Mazidi, Mohsen [1 ,2 ]
Rezaie, Peyman [3 ]
Karimi, Ehsan [3 ]
Kengne, Andre Pascal [4 ,5 ]
机构
[1] Chinese Acad Sci, Inst Genet & Dev Biol, Key State Lab Mol Dev Biol, Beijing, Peoples R China
[2] Univ Chinese Acad Sci IC UCAS, Int Coll, Inst Genet & Dev Biol, West Beichen Rd, Chaoyang, Peoples R China
[3] Mashhad Univ Med Sci, Sch Med, Biochem & Nutr Res Ctr, Mashhad, Iran
[4] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa
[5] Univ Cape Town, Cape Town, South Africa
关键词
Meta-analysis; Bile acid sequestrants; Fasting blood glucose; Lipid profile; TYPE-2; DIABETES-MELLITUS; IMPROVES GLYCEMIC CONTROL; COLESEVELAM HYDROCHLORIDE; DOUBLE-BLIND; INSULIN-RESISTANCE; LDL CHOLESTEROL; THERAPY; COLESTIMIDE; COMBINATION; HCL;
D O I
10.1016/j.ijcard.2016.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To undertake a systematic review andmeta-analysis of prospective clinical studies to determine the effect of bile acid sequestrants (BAS) on lipid profile and blood glucose concentrations. Method: PubMed-Medline, Web of Science, Cochrane Database and Google Scholar databases were searched (up until August 2016) to identify prospective studies evaluating the impact of BASs on the cardio-metabolic profile. Random effects model meta-analysis was used for quantitative data synthesis. Sensitivity analysis was conducted using the leave-one-out method. Heterogeneity was quantitatively assessed using the I-2 index. Systematic review registration: CRD42016035973. Results: From a total of 769 entries identified, 15 studies were included in the final analysis. The meta-analysis indicated a significant reduction in fasting serum triglyceride concentrations following treatment with BASs (weighted mean difference [WMD] 0.54 mg/dL, 95% CI 0.43 to 0.65, heterogeneity p = 0.021; I-2 54.2%, n = 11 studies). The WMDs for total serum cholesterol (TC) was -1.18 mg/dL (95% CI -1.30 to -1.06, heterogeneity p = 0012; I-2 63.1%, n = 11 studies), 0.126 mg/dL (95% CI 0.02 to 0.22, heterogeneity p = 0.231; I-2 43.2%, n = 11 studies) for HDL-cholesterol, and-0.24 mg/dL (95% CI-0.35 to-0.14, heterogeneity p = 0.562; I-2 23.1%, n = 10 studies) for LDL-cholesterol, and -2.10 mg/dL (95% CI -2.84 to -1.36, heterogeneity p = 0.200; I-2 42.6%, n = 11 studies) fasting blood glucose (FBG) and -0.83% (95% CI -1.08 to -0.57, heterogeneity p = 0.856; I-2 20.9%, n = 11 studies) for HbA1c. These findings were robust in sensitivity analyses. Conclusions: This meta-analysis suggests that therapy with BAS significantly improves HDL-C, LDL-C, and glycemic markers including fasting blood glucose, HbA1c levels, while deteriorating triglyceride levels. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:850 / 857
页数:8
相关论文
共 50 条
  • [1] Effects of Garlic on Glucose Parameters and Lipid Profile: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
    Zhao, Xinyu
    Cheng, Tao
    Xia, Hui
    Yang, Yanhong
    Wang, Shaokang
    NUTRIENTS, 2024, 16 (11)
  • [2] Effects of melatonin supplementation on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials
    Mohammadi-Sartang, Mohsen
    Ghorbani, Mohammad
    Mazloom, Zohreh
    CLINICAL NUTRITION, 2018, 37 (06) : 1943 - 1954
  • [3] The effect of saffron supplementation on blood glucose and lipid profile: A systematic review and meta-analysis of randomized controlled trials
    Asbaghi, Omid
    Soltani, Sepideh
    Norouzi, Noushin
    Milajerdi, Alireza
    Choobkar, Saeed
    Asemi, Zatollah
    COMPLEMENTARY THERAPIES IN MEDICINE, 2019, 47
  • [4] Bile Acid Sequestrants for Glycemic Control in Type 2 Diabetes: A Systematic Review With Meta-Analysis of Randomized Controlled Trials
    Hansen, Morten
    Mikkelsen, Kristian H.
    Sonne, David P.
    Gluud, Lise L.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES, 2013, 62 : A305 - A305
  • [5] Efficacy of Bile Acid Sequestrants in the Treatment of Bile Acid Diarrhea: A Meta-Analysis of Randomized Controlled Trials
    Soares, Giulia Almiron R.
    Godoi, Amanda
    Marcolin, Patricia
    Piredda, Gabriel
    Laia, Estella
    Rodrigues, Airton Zogaib
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024,
  • [6] The effects of Garcinia cambogia (hydroxycitric acid) on lipid profile: A systematic review and meta-analysis of randomized controlled trials
    Amini, Mohammad Reza
    Rasaei, Niloufar
    Jalalzadeh, Moharam
    Akhgarjand, Camellia
    Hashemian, Maryam
    Jalali, Parisa
    Hekmatdoost, Azita
    PHYTOTHERAPY RESEARCH, 2024, 38 (02) : 1028 - 1043
  • [7] Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials
    Hansen, Morten
    Sonne, David P.
    Mikkelsen, Kristian H.
    Gluud, Lise Lotte
    Vilsboll, Tina
    Knop, Filip K.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (05) : 918 - 927
  • [8] Effects of sumac supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials
    Bahari, Hossein
    Taheri, Shaghayegh
    Namkhah, Zahra
    Barghchi, Hanieh
    Arzhang, Pishva
    Nattagh-Eshtivani, Elyas
    PHYTOTHERAPY RESEARCH, 2024, 38 (01) : 241 - 252
  • [9] Effects of Sumac Supplementation on Lipid Profile: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Jafari, Ali
    Nezhad, Bahare Parsi
    Alaghi, Alireza
    PHYTOTHERAPY RESEARCH, 2024, 38 (12) : 5985 - 5987